PRAH - PRAヘルス・サイエンシズ (PRA Health Sciences Inc.)

PRAHのニュース

   Should I Buy PRA Health Sciences Inc (PRAH)?  2021/06/29 12:43:44 Insider Monkey
   Robert W. Baird Stick to Their Hold Rating for PRA Health Sciences By Investing.com  2021/06/29 09:05:23 Investing.com
Robert W. Baird Stick to Their Hold Rating for PRA Health Sciences
   PRA Health Sciences Inc (PRAH): Price Now Near $174.55; Daily Chart Shows An Uptrend on 100 Day Basis  2021/05/21 15:09:51 ETF Daily News
It''s been a feast for bulls operating on an hourly timeframe, as prah has now gone up 8 of the past 10 hours. The post PRA Health Sciences Inc (PRAH): Price Now Near $174.55; Daily Chart Shows An Uptrend on 100 Day Basis appeared first on ETF Daily News .
   SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PRAH, WSFS, STAY, NTEC, MX; Shareholders are Encouraged to Contact the Firm  2021/05/13 23:15:00 PR Newswire
NEW YORK, May 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: PRA Health Sciences, Inc. (NASDAQ: PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties
   PRA Health Sciences, Inc.: PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma  2021/05/13 20:05:00 FinanzNachrichten
Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data - speeding up drug development and aligning with the 21st Century Cures Ac
   The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx  2021/04/29 12:15:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ: AXNX ) Boston Scientific Corporation (NYSE: BSX ) (reacted to first-quarter results) Celcuity Inc. (NASDAQ: CELC ) Celldex Therapeutics, Inc. (NASDAQ: CLDX) Galectin Therapeutics Inc. (NASDAQ: GALT ) Horizon Therapeutics Public Limited Company (NASDAQ: HZNP ) Insulet Corporation (NASDAQ: PODD ) Integra LifeSciences Holdings Corporation (NASDAQ: IART ) (announced first-quarter results) Lantheus Holdings, Inc. (NASDAQ: LNTH ) MacroGenics, Inc. (NASDAQ: MGNX ) NuVasive, Inc. (NASDAQ: NUVA) PRA Health Sciences, Inc. (NASDAQ: PRAH ) ShockWave Medical, Inc. (NASDAQ: SWAV ) Verastem, Inc. (NASDAQ: VSTM ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows April 28) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Decibel Therapeutics, Inc. (NASDAQ: DBTX ) IRadimed Corporation (NASDAQ: IRMD ) Lucira Health, Inc. (NASDAQ: LHDX ) Mesoblast Limited (NASDAQ: MESO ) Protara Therapeutics, Inc. (NASDAQ: TARA ) PTC Therapeutics, Inc. (NASDAQ: PTCT ) Stocks In Focus Adverum Shares Sink On Serious Adverse Event Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
   Global Pre-Clinical Contract Research Services Market Growth Status and Outlook by 2026 | Envigo Corporation, MPI research, Eurofins Scientific, PRA Health Sciences, Inc, Wuxi AppTec, Medpace  2021/03/18 11:06:07 OpenPR
The Pre-Clinical Contract Research Services Market delivers a comprehensive study of the market, including its dynamics, structure, characteristics, Key players, growth and demand drivers, etc. As a Complete Analysis report, it covers all details inside analysis and outlook according to
   Robert W. Baird Stick to Their Buy Rating for PRA Health Sciences By Investing.com  2021/03/16 09:03:41 Investing.com
Robert W. Baird Stick to Their Buy Rating for PRA Health Sciences
   INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRAH, MIK, WSFS, TLND, SVBI; Shareholders are Encouraged to Contact the Firm  2021/03/12 03:39:00 PR Newswire
NEW YORK, March 11, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: PRA Health Sciences, Inc. (NASDAQ: PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties…
   Dublin will be home to major clinical research following $12bn Icon deal  2021/03/03 09:47:33 SiliconRepublic
Two major contract research organisations will combine as Ireland’s Icon acquires US company PRA Health for $12bn.
   Contract Research Organizations Market Size, Share, Analysis 2027 | Top key players – Laboratory Corporation Of America Holdings (covance), Iqvia, Syneos Health, Paraxel International Corporation, Pra Health Sciences, Pharmaceutical Product Development  2021/02/03 11:32:01 OpenPR
Contract Research Organizations Market Size, Share, Analysis 2027 | Top key players – Laboratory Corporation Of America Holdings (covance), Iqvia, Syneos Health, Paraxel International Corporation, Pra Health Sciences, Pharmaceutical Product Development (ppd), Charles River Laboratories International Inc (crl), Icon
   The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa  2021/01/22 12:22:33 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Acasti Pharma Inc (NASDAQ: ACST ) Alimera Sciences Inc (NASDAQ: ALIM ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Chimerix Inc (NASDAQ: CMRX ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive results for its COVID-19 antibody treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inari Medical Inc (NASDAQ: NARI ) INmune Bio Inc (NASDAQ: INMB ) ( INSM ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Inventiva ADR Representing Ord Shs (NASDAQ: IVA ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Merus NV (NASDAQ: MRUS ) Neuronetics Inc (NASDAQ: STIM ) OncoSec Medical Inc (NASDAQ: ONCS ) (announced common stock offering) PRA Health Sciences Inc (NASDAQ: PRAH ) Precision BioSciences Inc (NASDAQ: DTIL ) Profound Medical Corp (NASDAQ: PROF ) Renalytix AI PLC (NASDAQ: RNLX ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Surface Oncology Inc (NASDAQ: SURF ) Syneos Health Inc (NASDAQ: SYNH ) Synlogic Inc (NASDAQ: SYBX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps None of the biotech/medical device/diagnostic stocks hit 52-week highs in the session.
   The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations  2021/01/13 12:25:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
   Contract Research Organization Market to Witness Huge Growth by 2024| Key Players are IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Syneos Health Inc, PRA Health Sciences, Medpace Holdings Inc and Wuxi AppTec Co Ltd  2021/01/11 14:21:10 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Discovery): Insights, Trends and Forecast (2020-2024)”. China CRO market value is anticipated to reach US$27.04 billion in 2024, growing
   Pre Clinical CROs market 2027 Top Players : ovance, Inc., Charles River, Eurofins Scientific, PRA Health Sciences  2020/12/09 11:35:55 OpenPR
The global Pre Clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.4 Mn in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027. The report highlights the trends prevalent

calendar